Literature DB >> 8828218

Requirement for the Candida albicans FAS2 gene for infection in a rat model of oropharyngeal candidiasis.

X J Zhao1, G E McElhaney-Feser, W H Bowen, M F Cole, S E Broedel, R L Cihlar.   

Abstract

The virulence of Candida albicans strains deficient in fatty acid synthase activity by virtue of disruption/deletion of the FAS2 gene was examined in a rat model of oropharyngeal candidiasis. The FAS2 alleles of C. albicans CAI4 (delta ura3::imm434/delta ura3::imm434) were sequentially disrupted with a cassette that included a portion of FAS2 from which a 984 bp fragment containing the FAS condensing reaction domain was deleted and replaced with hisG-URA3-hisG sequences. Verification of fatty acid synthase inactivation was obtained from assays of enzyme activity. Strains in which a single allele was disrupted (CFD1 and CFD3) exhibited an approximately 20% reduction in activity, when compared to wild-type. In addition, fatty acid synthase activity was abolished in a FAS2 null mutant strain (CFD2), and growth of CFD2 occurred only when the growth medium was supplemented with Tween 40 and certain fatty acids. Strain CFD2 was avirulent in the rat model, indicating that fatty acid synthase activity is required for C. albicans oropharyngeal infection. Strains with a single FAS2 allele disruption colonized the oral cavity, but the number of cells recovered from infected animals was approximately fivefold less than for the parental strain. The results suggest that FAS may be exploited as a possible target for the development of new antifungal agents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828218     DOI: 10.1099/00221287-142-9-2509

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  9 in total

1.  The stearoyl-coenzyme A desaturase 1 is essential for virulence and membrane stress in Candida parapsilosis through unsaturated fatty acid production.

Authors:  Long Nam Nguyen; Attila Gacser; Joshua D Nosanchuk
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

2.  The inhibitory effect of cerulenin to yeasts is fungicidal.

Authors:  Long Nam Nguyen; Joshua D Nosanchuk
Journal:  Commun Integr Biol       Date:  2011-11-01

3.  Avirulence of Candida albicans FAS2 mutants in a mouse model of systemic candidiasis.

Authors:  X J Zhao; G E McElhaney-Feser; M J Sheridan; S E Broedel; R L Cihlar
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

4.  Fatty acid synthase impacts the pathobiology of Candida parapsilosis in vitro and during mammalian infection.

Authors:  Long Nam Nguyen; David Trofa; Joshua D Nosanchuk
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

Review 5.  Animal models of mucosal Candida infection.

Authors:  Julian R Naglik; Paul L Fidel; Frank C Odds
Journal:  FEMS Microbiol Lett       Date:  2008-04-16       Impact factor: 2.742

6.  RT-PCR analysis of Candida albicans ALS gene expression in a hyposalivatory rat model of oral candidiasis and in HIV-positive human patients.

Authors:  Clayton B Green; Sandra Manfra Marretta; Georgina Cheng; Fady F Faddoul; E J Ehrhart; Lois L Hoyer
Journal:  Med Mycol       Date:  2006-03       Impact factor: 4.076

7.  Fatty acid synthesis is essential for survival of Cryptococcus neoformans and a potential fungicidal target.

Authors:  Methee Chayakulkeeree; Thomas H Rude; Dena L Toffaletti; John R Perfect
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

8.  A GX2GX3G motif facilitates acyl chain sequestration by Saccharomyces cerevisiae acyl carrier protein.

Authors:  Rashima Prem; Usha Yadav; Monica Sundd
Journal:  J Biol Chem       Date:  2021-11-09       Impact factor: 5.157

9.  Inhibition of Candida parapsilosis fatty acid synthase (Fas2) induces mitochondrial cell death in serum.

Authors:  Long Nam Nguyen; Gabriele Vargas Cesar; Giang Thi Thu Le; David L Silver; Leonardo Nimrichter; Joshua D Nosanchuk
Journal:  PLoS Pathog       Date:  2012-08-30       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.